Literature DB >> 11342374

Pathologic splenic rupture as the presentation of mantle cell lymphoma.

A H Strickland1, K A Marsden, J McArdle, R M Lowenthal.   

Abstract

Pathologic splenic rupture in non-Hodgkin's lymphoma (NHL) is a rare event, with 32 cases previously reported. Initial presentation of NHL with this complication is even rarer. We report such a case in an 80-year-old man with mantle cell lymphoma (MCL). It is notable that of the previously reported cases of pathologic rupture, three have occurred in MCL, suggesting that patients with this uncommon subtype of NHL may be particularly vulnerable to pathologic splenic rupture. Following splenectomy the patient's disease behaved in a high-grade fashion. Despite an initially encouraging response, his disease ran an aggressive course and he succumbed within four months. This case demonstrates the presentation of MCL with pathologic splenic rupture, as well as the potentially highly malignant behaviour of the disease.

Entities:  

Mesh:

Year:  2001        PMID: 11342374     DOI: 10.3109/10428190109057971

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  4 in total

1.  Pathologic splenic rupture in a patient with follicular lymphoma.

Authors:  A P Dayama; R Kapoor; J Dass; G Singh; M Mahapatra; H P Pati
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-11-10       Impact factor: 2.576

Review 2.  Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature.

Authors:  Kogulakrishnan Kaniappan; Christopher Thiam Seong Lim; Pek Woon Chin
Journal:  BMC Cancer       Date:  2018-08-02       Impact factor: 4.430

Review 3.  613 cases of splenic rupture without risk factors or previously diagnosed disease: a systematic review.

Authors:  F Kris Aubrey-Bassler; Nicholas Sowers
Journal:  BMC Emerg Med       Date:  2012-08-14

4.  Pathologic Rupture of the Spleen in Mantle-Cell-Type Non-Hodgkin's Lymphoma.

Authors:  Christopher B Tan; Dhyan Rajan; Sumreen Majeed; Shadab Ahmed; Lester Freedman; Paul Mustacchia
Journal:  Case Rep Med       Date:  2012-04-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.